A major advance in cancer study is arising with the use of nanobodies to reactivate damaged p53. This crucial malignant inhibitor protein is frequently inactivated in several forms of tumors, resulting uncontrolled https://socialmediatotal.com/story7029820/nanobodies-reactivate-the-p53-protein-new-potential-hope-for-cancer-management